SG Americas Securities’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2M | Buy |
66,397
+49,123
| +284% | +$2.08M | ﹤0.01% | 1354 |
|
|
2025
Q4 | $800K | Sell |
17,274
-11,704
| -40% | -$490K | ﹤0.01% | 2189 |
|
|
2025
Q3 | $1.01M | Buy |
28,978
+19,796
| +216% | +$688K | ﹤0.01% | 1443 |
|
|
2025
Q2 | $272K | Sell |
9,182
-5,095
| -36% | -$145K | ﹤0.01% | 2080 |
|
|
2025
Q1 | $426K | Buy |
14,277
+578
| +4% | +$17.7K | ﹤0.01% | 1901 |
|
|
2024
Q4 | $392K | Sell |
13,699
-4,586
| -25% | -$152K | ﹤0.01% | 1558 |
|
|
2024
Q3 | $707K | Buy |
18,285
+1,470
| +9% | +$52.4K | ﹤0.01% | 1378 |
|
|
2024
Q2 | $541K | Buy |
16,815
+2,785
| +20% | +$96.6K | ﹤0.01% | 1642 |
|
|
2024
Q1 | $545K | Sell |
14,030
-4,214
| -23% | -$147K | ﹤0.01% | 1384 |
|
|
2023
Q4 | $562K | Buy |
18,244
+8,339
| +84% | +$209K | 0.01% | 1403 |
|
|
2023
Q3 | $221K | Buy |
+9,905
| New | +$226K | ﹤0.01% | 2259 |
|
|
2023
Q2 | – | Sell |
-24,472
| Closed | -$587K | – | 2442 |
|
|
2023
Q1 | $587K | Buy |
+24,472
| New | +$649K | 0.01% | 1594 |
|
|
2022
Q3 | – | Sell |
-7,404
| Closed | -$131K | – | 3235 |
|
|
2022
Q2 | $131K | Sell |
7,404
-9,883
| -57% | -$166K | ﹤0.01% | 2951 |
|
|
2022
Q1 | $352K | Sell |
17,287
-15,698
| -48% | -$297K | ﹤0.01% | 2105 |
|
|
2021
Q4 | $616K | Sell |
32,985
-5,756
| -15% | -$112K | ﹤0.01% | 2011 |
|
|
2021
Q3 | $765K | Buy |
+38,741
| New | +$838K | ﹤0.01% | 2132 |
|
|
2021
Q2 | – | Sell |
-9,918
| Closed | -$235K | – | 2906 |
|
|
2021
Q1 | $235K | Buy |
+9,918
| New | +$236K | ﹤0.01% | 2566 |
|
|
2020
Q3 | – | Sell |
-20,494
| Closed | -$359K | – | 2830 |
|
|
2020
Q2 | $359K | Buy |
20,494
+8,448
| +70% | +$165K | ﹤0.01% | 2385 |
|
|
2020
Q1 | $197K | Buy |
12,046
+5,990
| +99% | +$124K | ﹤0.01% | 2515 |
|
|
2019
Q4 | $125K | Buy |
+6,056
| New | +$101K | ﹤0.01% | 2817 |
|
|
2017
Q1 | – | Sell |
-9,891
| Closed | -$154K | – | 3307 |
|
|
2016
Q4 | $154K | Buy |
+9,891
| New | +$164K | ﹤0.01% | 2553 |
|
Other funds holding COLL
EAM
VCM
